Pfizer/BioNTech says three doses 'effective' against Omicron

By Agence France-Presse

Dec 09, 2021 3:51 pm

FRANKFURT: Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron strain, the companies warned Wednesday, but they stressed it was 'still effective' after a third jab.

The companies' news was called reassuring by experts, and came as the first independent data from labs around the world emerged, suggesting that the new variant is better at evading vaccine-trained immunity than those before it.

A member of the Western Cape Metro EMS (Emergency Medical Services) prepares Pfizer vaccines from an ambulance which has been converted to facilitate vaccinations at a Covid-19 vaccination event in Manenberg, which is part of the Vaxi-Taxi mobile vaccination drive, on December 08, 2021 in Cape Town. AFP PHOTO

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

China's biggest ship sails into PH waters

Panelo hits Sara's removal from NSC

Dire warnings issued over shear line

South Korea in political crisis after president resists arrest

Court says 'vague' search warrants invalid

Chinese Embassy mum on found drone

Go pushes for stronger measures to protect OFWs